What is Scotiabank's Estimate for Albemarle FY2025 Earnings?

Albemarle Co. (NYSE:ALB - Free Report) - Equities researchers at Scotiabank boosted their FY2025 earnings per share (EPS) estimates for shares of Albemarle in a report released on Monday, May 5th. Scotiabank analyst B. Isaacson now anticipates that the specialty chemicals company will post earnings of ($0.71) per share for the year, up from their previous forecast of ($0.94). Scotiabank currently has a "Sector Perform" rating and a $65.00 price target on the stock. The consensus estimate for Albemarle's current full-year earnings is ($0.04) per share. Scotiabank also issued estimates for Albemarle's FY2026 earnings at $1.50 EPS.

Albemarle (NYSE:ALB - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The specialty chemicals company reported ($0.18) earnings per share for the quarter, topping the consensus estimate of ($0.62) by $0.44. The business had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.18 billion. Albemarle had a negative net margin of 21.93% and a negative return on equity of 1.72%. The company's revenue was down 20.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.26 EPS.

Several other research firms have also weighed in on ALB. Clarkson Capital started coverage on shares of Albemarle in a research note on Tuesday, January 14th. They set a "buy" rating and a $112.00 target price for the company. BMO Capital Markets decreased their target price on shares of Albemarle from $150.00 to $140.00 in a research report on Wednesday, February 12th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Albemarle from $109.00 to $105.00 in a research note on Wednesday, February 12th. Wells Fargo & Company decreased their price target on Albemarle from $80.00 to $60.00 and set an "equal weight" rating for the company in a research note on Wednesday, April 9th. Finally, Evercore ISI downgraded shares of Albemarle from an "outperform" rating to an "inline" rating in a report on Wednesday, February 5th. Three analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Albemarle currently has an average rating of "Hold" and an average target price of $92.43.

Albemarle Stock Performance

Albemarle stock opened at $56.11 on Thursday. The company has a current ratio of 1.95, a quick ratio of 1.19 and a debt-to-equity ratio of 0.39. The stock has a 50 day moving average of $65.16 and a 200-day moving average of $83.49. The stock has a market cap of $6.60 billion, a P/E ratio of -5.01 and a beta of 1.71. Albemarle has a 52 week low of $49.43 and a 52 week high of $137.50.

Albemarle Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Friday, June 13th will be paid a dividend of $0.405 per share. This represents a $1.62 annualized dividend and a yield of 2.89%. The ex-dividend date of this dividend is Friday, June 13th. Albemarle's dividend payout ratio (DPR) is presently -14.57%.

Institutional Investors Weigh In On Albemarle

Institutional investors have recently added to or reduced their stakes in the company. Assetmark Inc. increased its holdings in Albemarle by 340.6% in the 4th quarter. Assetmark Inc. now owns 304 shares of the specialty chemicals company's stock worth $26,000 after acquiring an additional 235 shares during the last quarter. Trust Co. of Vermont lifted its position in shares of Albemarle by 606.5% during the fourth quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company's stock worth $28,000 after acquiring an additional 279 shares in the last quarter. SJS Investment Consulting Inc. purchased a new position in shares of Albemarle in the first quarter valued at $32,000. First Community Trust NA boosted its stake in Albemarle by 55.0% in the 4th quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company's stock worth $34,000 after purchasing an additional 142 shares during the period. Finally, Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Albemarle in the fourth quarter worth about $34,000. 92.87% of the stock is owned by institutional investors.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.